These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 38354597)
1. US Generic Antiseizure Medication Supply Chain: Observations from Analysis of US Government Databases. Javarayee P; Meylor J; Shahrukh S; Pollock S; Andrade-Machado R; Sah J; Patel H Seizure; 2024 Apr; 117():83-89. PubMed ID: 38354597 [TBL] [Abstract][Full Text] [Related]
2. Countries Manufacturing Pharmaceuticals for the US Market: A 10-Year Analysis of Public Data. Hatton RC; Leighton G; Englander L Ann Pharmacother; 2022 Oct; 56(10):1106-1112. PubMed ID: 35040353 [TBL] [Abstract][Full Text] [Related]
3. Shortages of antiseizure medications in Australia and the association with patient switching, and adherence in a community setting. Welton J; Stratton G; Schoeninger B; Low MH; Moody A; D'Souza W Epilepsy Behav; 2023 Apr; 141():109145. PubMed ID: 36913876 [TBL] [Abstract][Full Text] [Related]
4. Use of antiseizure medications and safety of branded versus generic formulations: A comparative study on Tuscan administrative databases. Giometto S; Baglietto L; Conte M; Vannacci A; Tuccori M; Mugelli A; Gini R; Lucenteforte E Epilepsy Behav; 2021 Apr; 117():107876. PubMed ID: 33714929 [TBL] [Abstract][Full Text] [Related]
5. Predictors of shortages of opioid analgesics in the US: Are the characteristics of the drug company the missing puzzle piece? Rodriguez-Monguio R; Naveed M; Seoane-Vazquez E PLoS One; 2021; 16(3):e0249274. PubMed ID: 33788898 [TBL] [Abstract][Full Text] [Related]
6. Greater need for treatment optimization in patients with epilepsy initiating adjunctive therapy: Results of a retrospective claims analysis of antiseizure medication drug load in the United States. Connor GS; Labiner DM; Schabert VF; Weingarten M; Wade CT; Stern S; Becker DA Epilepsy Behav; 2024 Mar; 152():109649. PubMed ID: 38277849 [TBL] [Abstract][Full Text] [Related]
7. Supply problems of antiseizure medication are common among epilepsy patients in Germany. Mann C; Maltseva M; von Podewils F; Knake S; Kovac S; Rosenow F; Strzelczyk A Epilepsy Behav; 2023 Jan; 138():108988. PubMed ID: 36423387 [TBL] [Abstract][Full Text] [Related]
8. Critical drug shortages: implications for emergency medicine. Mazer-Amirshahi M; Pourmand A; Singer S; Pines JM; van den Anker J Acad Emerg Med; 2014 Jun; 21(6):704-11. PubMed ID: 25039558 [TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
11. Bioequivalence and switchability of generic antiseizure medications (ASMs): A re-appraisal based on analysis of generic ASM products approved in Europe. Odi R; Franco V; Perucca E; Bialer M Epilepsia; 2021 Feb; 62(2):285-302. PubMed ID: 33426641 [TBL] [Abstract][Full Text] [Related]
12. Affordability of newer antiseizure medications in Asian resource-limited countries. Fong SL; Thuy Le MA; Lim KS; Khosama H; Ohnmar O; Savath S; Mogal Z; Cabral-Lim L; Hung SK; Asranna A; Hussain ME; Ng CW; Tan CT Epilepsia; 2023 Aug; 64(8):2116-2125. PubMed ID: 37243851 [TBL] [Abstract][Full Text] [Related]
13. Competition And Vulnerabilities In The Global Supply Chain For US Generic Active Pharmaceutical Ingredients. Socal MP; Ahn K; Greene JA; Anderson GF Health Aff (Millwood); 2023 Mar; 42(3):407-415. PubMed ID: 36791331 [TBL] [Abstract][Full Text] [Related]
14. Changes in the Use of Brand Name and Generic Medications and Total Prescription Cost Among Medicare Beneficiaries With Epilepsy. Terman SW; Lin CC; Kerr WT; DeLott LB; Callaghan BC; Burke JF Neurology; 2022 Aug; 99(8):e751-e761. PubMed ID: 35705496 [TBL] [Abstract][Full Text] [Related]
15. Incidence of and predictors for antiseizure medication gaps in Medicare beneficiaries with epilepsy: a retrospective cohort study. Terman SW; Niznik JD; Slinger G; Otte WM; Braun KPJ; Aubert CE; Kerr WT; Boyd CM; Burke JF BMC Neurol; 2022 Sep; 22(1):328. PubMed ID: 36050646 [TBL] [Abstract][Full Text] [Related]
16. Evolution of antiseizure medication use and cost in the United States of America 2006-2021. Sánchez Fernández I; Gaínza-Lein M; Amengual-Gual M; Barcia Aguilar C; Romeu A; Torres A; Jonas R; Douglass LM Seizure; 2023 Nov; 112():128-138. PubMed ID: 37832279 [TBL] [Abstract][Full Text] [Related]
17. Common Filing Deficiencies in Abbreviated New Drug Applications Containing Clinical Endpoint Studies. Fermaglich LJ; Chen R; Kim CY; Chuh EE; Thomas T; Shetty D; Lee J; Young J; Fan Y Ther Innov Regul Sci; 2019 Jan; 53(1):81-85. PubMed ID: 29719976 [TBL] [Abstract][Full Text] [Related]
18. The Evolution of Supply and Demand in Markets for Generic Drugs. Frank RG; McGuire TG; Nason I Milbank Q; 2021 Sep; 99(3):828-852. PubMed ID: 34075623 [TBL] [Abstract][Full Text] [Related]
19. Barriers to generic antiseizure medication use: Results of a global survey by the International League Against Epilepsy Generic Substitution Task Force. Niyongere J; Welty TE; Bell MW; Consalvo D; Hammond C; Leung H; Patsalos PN; Ryan M; Suansanae T; Zhou D; Zuellig H Epilepsia Open; 2022 Jun; 7(2):260-270. PubMed ID: 35124903 [TBL] [Abstract][Full Text] [Related]
20. Drug Shortages Prior to and During the COVID-19 Pandemic. Callaway Kim K; Rothenberger SD; Tadrous M; Hernandez I; Gellad WF; Devine JW; Hershey TB; Maillart LM; Suda KJ JAMA Netw Open; 2024 Apr; 7(4):e244246. PubMed ID: 38578641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]